Idiopathic

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Paul Hayes

Published July 4, 2009, 1:01 am, The Telegraph

Paul Hayes, 71, died Friday June 26, 2009, at a local Hospital of idiopathic pulmonary fibrosis, a devastating lung disease with no know cause or cure.

Discover News | Full Story


EC lifts treatment restrictions on Neupro

Published July 3, 2009, 5:49 am, PharmaBiz

UCB announced that Neupro (rotigotine transdermal patch) can now be prescribed to all patients with idiopathic Parkinson's disease in Europe and is newly available for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome (RLS) in adults.

Discover News | Full Story


New Discovery To Aid In Diagnosis And Treatment Of Kidney Disease

Published July 3, 2009, 4:08 am, Medical News Today

Researchers from Boston University School of Medicine (BUSM) in collaboration with scientists at the University of Louisville and the University of Nice Sophia Antipolis in France, have identified the target antigen PLA2R in patients with idiopathic membranous nephropathy (kidney disease), which has implications for the diagnosis and treatment of this disease.

Discover News | Full Story


Chinese veterinary medicine can help dog seizures

Published July 2, 2009, 4:46 pm, St. Louis Post-Dispatch

There are many causes for seizures in animals. The overall incidence of seizures in dogs is estimated at 1 percent, but goes up to 15-20 percent in purebred dogs.

Discover News | Full Story


New Product For Pfizer Specialty Takes Pulmonary Arterial Hypertension To Heart

Published July 2, 2009, 9:08 am, Medical News Today

Pfizer Australia announced that it has signed an agreement to acquire the local distribution rights for THELIN® (Sitaxentan sodium), an oral, once-daily highly selective endothelin receptor antagonist, indicated for the treatment of pulmonary arterial hypertension (PAH) in patients with NYHA/WHO Functional Class III symptoms to improve exercise ability.

Discover News | Full Story


Medarex To Receive Milestone Payment For The Approval Of Ilaris For The Treatment Of Cryopyrin-Associated Periodic ...

Published July 2, 2009, 7:08 am, Medical News Today

Medarex, Inc. (NASDAQ:MEDX) announced it will receive a milestone payment of an undisclosed amount from Novartis Pharma AG (Novartis), in connection with the marketing approval from the U.S.

Discover News | Full Story


Neupro(R), The Only Transdermal Patch For Restless Legs Syndrome, Now Available In The UK

Published July 2, 2009, 4:08 am, Medical News Today

The only transdermal patch in the UK for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome (RLS) in adults was launched by UCB. Applied once-a-day, Neupro® (rotigotine transdermal patch) allows for continuous drug delivery to provide stable drug levels in the bloodstream 24 hours a day and improves symptom control day and night.

Discover News | Full Story


Gene expression findings may lead to better classification & treatment of juvenile arthritis: Study

Published July 2, 2009, 3:48 am, PharmaBiz

Scientists have discovered gene expression differences that could lead to better ways to classify, predict outcome, and treat juvenile idiopathic arthritis (JIA). Eventually such findings could enable doctors to target more aggressive treatment to children at risk of more severe arthritis, while those likely to have milder disease could be spared the stronger treatments that carry a greater risk ...

Discover News | Full Story


Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, ...

Published July 1, 2009, 4:12 pm, Lancet

Idiopathic pulmonary fibrosis is a fatal disease for which no effective treatment exists. We assessed whether treatment with interferon gamma-1b improved survival compared with placebo in patients with idiopathic pulmonary fibrosis and mild-to-moderate impairment of pulmonary function.

Discover News | Full Story


New discovery to aid in diagnosis and treatment of kidney disease

Published July 1, 2009, 3:18 pm, PhysOrg

Researchers from Boston University School of Medicine (BUSM) in collaboration with scientists at the University of Louisville and the University of Nice Sophia Antipolis in France, have identified the target antigen PLA2R in patients with idiopathic membranous nephropathy (kidney disease), which has implications for the diagnosis and treatment of this disease. These findings appear in the July 2 ...

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a